다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Korean journal of family medicine : KJFM, v.34 no.5, 2013년, pp.298 - 306
Kim, Hyun Ok (Department of Family Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) , Lee, Jung Ah (Department of Family Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) , Suh, Hee Won (Department of Family Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) , Kim, Young Sik (Department of Family Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.) , Kim, Bum Soo (Haemalgeun Clinic, Incheon, Korea.) , Ahn, Eun Sook (Sungmo Family Medical Clinic, Uijeongbu, Korea.) , Roh, Young Jun (Purun Medical Clinic, Gangneung, Korea.) , Jung, Seong Gil (Sejong Clinic, Geoje, Korea.) , Kim, Jin Mok (Paradise Clinic, Busan, Korea.) , Kang, Moon Kuk (Chungdamwhite Clinic, Jinju, Korea.) , Ahn, In Soon (Yonsei Pediatric Clinic, Incheon, Korea.) , Park, Young Gyu (Daejin Medical Center, Seongnam, Korea.)
AI-Helper
BackgroundObesity is a complex problem that is now considered a chronic metabolic disease. In Korea, phentermine has been widely used for the treatment of obesity in the primary care setting since 2004. However, there have been very few studies on the safety and efficacy of phentermine. To investiga...
1 Bray GA The metabolic syndrome and obesity Totowa (NJ) Humana Press 2007
2 Ioannides-Demos LL Proietto J Tonkin AM McNeil JJ Safety of drug therapies used for weight loss and treatment of obesity Drug Saf 2006 29 277 302 16569079
3 World Health Organization International Association for the Study of Obesity International Obesity Task Force The Asia-Pacific perspective: redefining obesity and its treatment Sydney Health Communications Australia 2000
4 Statistics Korea Population projections for Korea [Internet] Daejeon Statistics Korea c1996-2009 cited 2009 Nov 11 Available from: http://www.kosis.kr/eng/
5 Kaplan LM Pharmacological therapies for obesity Gastroenterol Clin North Am 2005 34 91 104 15823441
6 Halford JC Boyland EJ Blundell JE Kirkham TC Harrold JA Pharmacological management of appetite expression in obesity Nat Rev Endocrinol 2010 6 255 269 20234354
7 Ioannides-Demos LL Piccenna L McNeil JJ Pharmacotherapies for obesity: past, current, and future therapies J Obes 2011 2011 179674 21197148
8 Alexander M Rothman RB Baumann MH Endres CJ Brasic JR Wong DF Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis Synapse 2005 56 94 99 15729739
9 Cannistra LB Gaasch WH Appetite-suppressing drugs and valvular heart disease Cardiol Rev 1999 7 356 361 11208248
10 Sachdev M Miller WC Ryan T Jollis JG Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies Am Heart J 2002 144 1065 1073 12486432
11 Kim BS Kim YS Ahn ES Roh YJ Jung SG Kim MJ Postmarketing surveillance study on the efficacy and safety of phendimetrazine in patients with obesity Korean J Health Promot 2010 10 97 103
12 Choi CJ Kim KS Kim SR Kang JH Park HS Double-blind, parallel-group, placebo-controlled multi-center clinical trial for evaluating the efficacy and safety of phentermine hydrochloride in obese patients Korean J Obes 2005 14 155 162
13 Park HS Kim KS Kim BT Lee KW Ahn CW Choi WH Double-blind, randomized, multi-center, comparative clinical trial of sibutramine mesilate with sibutramine hydrochloride for evaluating efficacy and safety in obese patients Korean J Obes 2008 17 82 90
14 Kim KK Cho HJ Kang HC Youn BB Lee KR Effects on weight reduction and safety of short-term phentermine administration in Korean obese people Yonsei Med J 2006 47 614 625 17066505
15 Kay JM Dietary pulmonary hypertension Thorax 1994 49 Suppl S33 S38 7974325
16 Rostagno C Caciolli S Felici M Gori F Neri Serneri GG Dilated cardiomyopathy associated with chronic consumption of phendimetrazine Am Heart J 1996 131 407 409 8579044
17 Kim YS Sunwoo S Lee HR Lee KM Park YW Shin HC Determinants of non-compliance with lipid-lowering therapy in hyperlipidemic patients Pharmacoepidemiol Drug Saf 2002 11 593 600 12462137
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.